Open Access

Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer

  • Authors:
    • Yu-Zhou Qin
    • Xue-Cheng Xie
    • Hai-Zhou Liu
    • Hao Lai
    • Hai Qiu
    • Lian-Ying Ge
  • View Affiliations

  • Published online on: April 1, 2015     https://doi.org/10.3892/or.2015.3892
  • Pages: 2728-2736
  • Copyright: © Qin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The overexpression of human telomerase reverse transcriptase (hTERT) has been associated with the invasion and metastasis of colorectal cancer (CRC) and has received extensive attention, although the underlying mechanism involved remains unclear. The aim of the present study was to screen and preliminarily validate new tumor‑suppressor microRNAs (miRNAs) that potentially inhibit hTERT expression and to assess its clinical significance. Screening for downregulated miRNAs in CRC tissues was performed by retrieving and analysing microRNA microarray data. miRNA candidates were then filtered by bioinformatics analysis. The expression of miRNAs candidates was verified by quantitative polymerase chain reaction in the CRC and corresponding normal tissues. Immunohistochemistry (IHC) was used for the detection of hTERT protein expression. Spearman's correlation coefficient between miRNA candidates and hTERT protein expression was calculated (r) to identify hTERT-targeting miRNAs. A survival analysis was performed to assess the prognostic significance of hTERT-targeting miRNAs in CRC. Eight miRNAs with the potential to interact with hTERT were predicted: miR‑29c-3p, miR‑124-3p, miR‑133a-3p, miR‑133b, miR-138-5p, miR-150-5p, miR-378a-3p and miR-422a, respectively. Following detection of the miRNAs using RT-qPCR, miR-29c-3p was excluded. miR-138-5p and miR-422a were observed to potentially interact with hTERT (r=-0.362, P=0.001; r=-0.306, P=0.005, respectively). The Kaplan-Meier survival curves demonstrating high- vs. low-expression group of miR‑422a showed a highly significant difference in CRC patients (P=0.024), which suggests that the downregulation of miR-422a was associated with a poorer prognosis. The results indicated that miR-138-5p and miR-422a potentially inhibited hTERT expression in CRC, and suggest a potential application of miR‑422a in prognosis prediction and CRC treatment.

Introduction

Eukaryotic chromosomes are composed of tandemly repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex (1). Telomerase enables cancer cells to achieve replicative immortality, which is one of the hallmarks of cancer (2). Telomerase activity is currently the most general molecular marker for the identification of human cancer and can be detected in 85–90% of all tumors (3). Human telomerase reverse transcriptase (hTERT), which confers the catalytic activity of telomerase, is the restricting factor for telomerase activity (4). Investigations have shown that hTERT has a significant role in cancer tumorigenesis, growth, migration and invasion (5). Clinical studies have also proven that the overexpression of hTERT is associated with cancer progression and poor outcomes, although the underlying mechanism remains unclear (6). The majority of studies have focused on the co-regulation of hTERT via transcriptional regulation, the presence or absence of various activators and repressors, as well as the epigenetic pathways of DNA methylation and histone modifications (7). Few studies aimed to examine the regulation of hTERT via post-transcription.

microRNAs (miRNAs) are thought to control gene expression at the post-transcriptional level by degrading or repressing target messenger RNAs (mRNAs) (8). miRNAs are a class of newly identified eukaryotes, highly conserved, with a length of ~18–24 nt endogenous non-coding single-stranded RNA. They have crucial regulatory functions in cell differentiation, proliferation, and apoptosis (9). Each miRNA has multiple target genes, with well over one third of human genes appearing to be conserved miRNA targets (10). Recent findings have shown that the altered expression pattern of miRNAs is involved in many forms of cancer as oncogenes and tumor suppressors, playing an important role in cancer occurrence, development and progression, especially in colorectal cancer (CRC) (11).

Three different miRNAs (miR138 in human anaplastic thyroid carcinoma cell lines, miR-1207 and miR1266 in gastric cancer) have been identified that may influence hTERT expression (12,13). Since a miRNA can affect hundreds of target gene regulation, a gene can also be affected by molecular regulation of multiple miRNAs. Therefore, other miRNAs may be involved in the post-transcriptional regulation of hTERT.

Through retrieval of microRNA microarray data and biological information technology analysis, the expression of miRNAs with the potential to directly regulate hTERT was downregulated. Reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR) was used to verify the expression of these miRNAs in the CRC and corresponding normal tissues. Subsequently, immunohistochemistry (IHC) was used in the detection of hTERT protein expression in the same samples. A preliminary validation of the miRNAs with the potential to regulate hTERT was obtained by identifying whether there is a negative relationship between expression of miRNAs and the hTERT IHC data.

Materials and methods

Patients, tissue samples and follow-up

The CRC and corresponding normal tissues were retrospectively recruited from 84 patients with CRC at the Tumor Hospital of Guangxi Medical University between 2007 and 2010. The present study was approved by the Institutional Review Board of the Guangxi Medical University. None of the CRC patients had undergone neo-adjuvant radiotherapy, chemotherapy or other treatment prior to surgery. Pathological diagnosis was also standardised and reviewed by committee criteria, chaired by a senior academic pathologist. Patient clinicopathological information and follow-up data of CRC were available from the documents of the hospital. The clinicopathological characteristics of patients are shown in Table I.

Table I

The correlation between miR-138-5p and miR-422a expression and clinicopathological parameters in 84 colorectal cancer patients.

Table I

The correlation between miR-138-5p and miR-422a expression and clinicopathological parameters in 84 colorectal cancer patients.

ParametersTotal (n=84)miR-138-5p
P-valuemiR-422a
P-value
Low (n=43)High (n=41)Low (n=42)High (n=42)
Age (years)0.1660.450
 <5021813912
 ≥506335283330
Gender0.4970.381
 Male4622242125
 Female3821172117
Tumor size (cm)0.1300.378
 <53615212016
 ≥54828202226
Tumor site0.2570.659
 Colon4822262325
 Rectum3621151917
Differentiation0.0710.825
 G1+G24921282425
 G3+G43522131817
T0.2380.242
 T1+T2149595
 T3+T47034363337
N0.1260.023a
 Negative3012181020
 Positive5431233222
M0.000a0.287
 Negative6627393135
 Positive18162117
TNM stage0.1230.064
 I+II2811171018
 III+IV5632243224

{ label (or @symbol) needed for fn[@id='tfn1-or-33-06-2728'] } Statistical analysis was performed by the χ2 test.

a P<0.05 was considered statistically significant.

Retrieval of microRNA microarray data

Gene Expression Omnibus (GEO) is a public functional genomics data repository supporting MIAME compliant data submissions. The GEO datasets were searched for relevant studies using the terms: (colon or rectum or rectal or colorectal) and (cancer or tumor or neoplasm). The study type was limited to ‘non-coding RNA profiling by array’, the organism was ‘homo sapiens’ and the attribute name was ‘tissue’. The dataset was included in our analysis when the certain criteria were met, i.e., the dataset was required to i) be microarray data expression of miRNAs in CRC; ii) be controlled studies in the CRC and corresponding normal tissue; iii) include ≥3 samples and iv) be available for download.

Biological information technology

The common analysis methods of extract differentially regulated miRNAs from the dataset included previously were: significance analysis of microarrays (SAM), CyberT and rank products (RP), of which CyberT is the most commonly used analytical tool of computational biology, and bioinformatics analysis as its algorithm can be completely implemented in the linear models for the microarray data (Limma) package (14). In this study, the data were analyzed by using language R (3.2 versions). To test for differential expression, CyberT algorithm and the bayesian adjusted t-statistics from the Limma package statistical methods were used (15,16). A multiple-testing correction based on the false discovery rate (FDR) was performed.

The miRWalk (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/) is a publically available comprehensive resource, hosting the predicted as well as the experimentally validated miRNA-target interaction pairs (17). miRWalk online software was used to predict miRNAs with the potential to interact with hTERT. The candidate hTERT-targeting miRNAs were selected for analysis in the subsequent experiments.

Reverse transcriptase quantitative polymerase chain reaction

Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was performed to detect the included miRNAs expression. Total RNA was extracted from tissue samples using a Qiagen miRNeasy Mini kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s instructions. The total RNA was then eluted in a 30-μl volume of elution buffer. RNAs were quantified by Nanodrop 2000 (PeqLab Biotechnology GmbH, Erlangen, Germany). RNA samples were converted to cDNA using miScript II RT kit (Qiagen). qPCR was performed in a total volume of 20 μl reaction mixture containing cDNA product, specific primers for each miRNA (Invitrogen, Carlsbad, CA, USA), miScript Universal primer (Qiagen), SYBR-Green qPCR Master Mix (Thermo Fisher Scientific, Waltham, MA, USA) and nuclease-free water. The U6 snRNA gene was used as an internal control. The sequences of the specific forward primers are shown in Table II. PCR reactions were conducted at 95°C for 7 min, followed by 40 cycles of 95°C for 10 sec, and 60°C for 30 sec in a Mx3000P Real-Time Quantitative PCR system (Agilent Technologies, Inc., Santa Clara, USA). To minimize data variation in separate runs, paired cancer and corresponding normal tissues from the same patient were detected on the same runs. The Ct value was calculated using MxPro-Mx3000P software (Agilent Technologies) using the automatic threshold setting. The reactions were run in triplicate. Results were presented as the levels of expression following normalization to U6 using the 2−Δ∆Ct method (18).

Table II

PCR primer sequences for miRNAs and U6.

Table II

PCR primer sequences for miRNAs and U6.

GenesForward primers (5′–3′)
hsa-miR-133a-3p TTTGGTCCCCTTCAACCAGCTG
hsa-miR-133b TTTGGTCCCCTTCAACCAGCTA
hsa-miR-422a ACTGGACTTAGGGTCAGAAGG
hsa-miR-29c-3p GCTAGCACCATTTGAAATCGGTTA
hsa-miR-124-3p TAAGGCACGCGGTGAATG
hsa-miR-138-5p GCAGCTGGTGTTGTGAATCA
hsa-miR-150-5p CTCCCAACCCTTGTACCAGTG
hsa-miR-378a-3p ACTGGACTTGGAGTCAGAAGGC
U6 CGCAAGGATGACACGCAAATTCGT
Immunohistochemistry

Sections (4-μm) were cut from the selected paraffin blocks and dried overnight at 37°C. The sections were dewaxed and rehydrated, exposed to 3% H2O2 solution for 10 min to block endogenous peroxidase and subjected to antigen retrieval in Tris-EDTA (pH 9.0). Subsequently, the slides were incubated with the rabbit monoclonal antibody against hTERT (1:100; Abcam, Cambridge, MA, USA), overnight at 4°C. Following three washes in 0.01 mol/l phosphate-buffered saline (PBS, pH=7.4), labeling was detected by adding a secondary antibody for 15 min at room temperature and diaminobenzidine (both from Maxim-Bio, Fuzhou, China) after washing in PBS again. The sections were then counterstained with hematoxylin, dehydrated, and mounted. Negative controls were conducted by replacing the primary antibody with PBS.

The sections were blindly and independently assessed microscopically by two well-trained pathologists. For the assessment of hTERT, five high-power fields in each specimen were randomly selected, and yellow or brown staining of the cytoplasm or nuclear was considered positive staining. The hTERT immunostaining score was calculated with a semi-quantitative scoring system as the intensity (0, no staining; 1, weak staining; 2, moderate staining; 3, strong staining) and the percentage (extent staining) of tumor cells that were stained (0, <10% of tumor cells stained; 1, 10–50% of positive cells; 2, >50 and <75% of positive cells; 3, >75% of positive cells). An overall score was obtained as the product of the intensity and distribution of positive staining (19). Cases with 0 points were considered to be negative (0), cases with a final score of 1–3 as weakly positive (1+), cases with a final score of 4–7 as moderately positive (2+) and cases with a final score of >7 as strongly positive (3+).

Statistical analysis

Statistical analysis was performed using Statistical Program for Social Sciences (SPSS) software, version 16.0 (SPSS Inc., Chicago, IL, USA). RT-qPCR data were expressed as medians (IQR, interquartile range). Possible differences between the CRC and corresponding normal tissue groups were analyzed using the Wilcoxon’s signed-rank test. Correlations between the expression of hTERT proteins (immunohistochemical scores) with the expression of miRNAs were evaluated using the Spearman’s rank-order correlation coefficient. Survival curves were obtained by the Kaplan-Meier method. A comparison between curves was made using the log-rank test. The tests were performed as two-tailed and the level of significance was set as P<0.05.

Results

Identification of downregulated miRNAs through retrieval of microRNA microarray data and language R analysis

A total of eight datasets fulfilled the inclusion criteria for our analysis: GSE10259, GSE33127, GSE35602, GSE38389, GSE39845, GSE49246, GSE18392 and GSE35982, respectively. Subsequently, we used language R to analyze the eight included data. First, 173 significantly downregulated miRNAs were selected with log2FC<−0.5 and a P-value of <0.05 by analyzing language R. Second, according to the number of chip data source arrangement (highest score, 8 points and lowest score 1 point), 45 significantly downregulated miRNAs with a frequency of ≥2 were identified. An intersection of the 45 miRNAs and downregulated miRNAs provided from the published literature corresponding to the eight microarray data was performed. Thirty-two significantly downregulated miRNAs in CRC tissue were found.

Identification of candidate hTERT-targeting miRNAs through biological information technology

Initially, 359 miRNAs were found by using miRWalk online software. Points ≥2 were selected, duplicate values were removed, and ultimately 125 hTERT regulation-related miRNAs were obtained according to the integral arrangement (results of the 1 point represent only one software prediction, with a maximum of 6 points and a minimum of 1 point). miRNAs were obtained by the intersection of the 32 significantly downregulated miRNAs and the 125 miRNAs associated with the regulation of hTERT. Eight miRNAs with the potential to interact with hTERT were predicted: miR-29c-3p, miR-124-3p, miR-133a-3p, miR-133b, miR-138-5p, miR-150-5p, miR-378a-3p and miR-422a, respectively.

Validation of the 8 selected miRNAs by RT-qPCR

To validate the relative expression levels of 8 selected miRNAs in CRC and corresponding normal tissues, we performed qPCR experiments. The results revealed that the expression level in CRC tissues of miR-124-3p, miR-133a-3p, miR-133b, miR-138-5p, miR-150-5p, miR-378a-3p and miR-422a (P<0.0001 for all) were statistically significantly downregulated when compared with the corresponding normal tissues. However, there was no significant difference in the levels of miR-29c-3p (P=0.260, Fig. 1 and Table III). The amplification curves and the melting curves of 8 miRNAs and U6 in the qPCR phase are shown in Fig. 2.

Table III

miRNAs levels of colorectal cancer and corresponding normal tissue groups using RT-qPCR.

Table III

miRNAs levels of colorectal cancer and corresponding normal tissue groups using RT-qPCR.

microRNAMedian (25–75th)
P-value
Cancer groupNormal group
miR-29c-3p0.193822 (0.096222–0.405425)0.181904 (0.070936–0.449074)0.0260
miR-124-3p0.001082 (0.000298–0.003321)0.008278 (0.002707–0.028471)<0.0001
miR-133a-3p0.019915 (0.004420–0.073774)0.187506 (0.083645–0.456176)<0.0001
miR-133b0.001285 (0.000296–0.005439)0.016779 (0.007922–0.043813)<0.0001
miR-138-5p0.002022 (0.00380–0.010544)0.010097 (0.004016–0.025342)<0.0001
miR-150-5p0.018194 (0.007202–0.064146)0.060581 (0.020490–0.197861)<0.0001
miR-378a-3p0.027426 (0.009510–0.114644)0.318763 (0.145602–0.820874)<0.0001
miR-422a0.050255 (0.014860–0.134671)0.273810 (0.117263–0.488233)<0.0001

[i] RT-qPCR, reverse-transcriptase quantitative polymerase chain reaction.

Immunohistochemical expression of hTERT protein in paraffin sections and the correlations with expression levels of the 7 verified miRNAs

Positive hTERT inmunoreactivity was observed in cancer tissue of 60 patients, while in 24 patients it was negative. As shown in Fig. 3, the positive expression of hTERT was localized to the cytoplasm or nuclei in colorectal tumor cells. Spearman’s rank-order correlation coefficient between miRNAs and hTERT protein expression was calculated (r). As the frequency distribution for miRNAs in the group was non-parametric, the median (non-parametric distribution) was used as the cut-off level of expression to divide patients into the high- and low-expression groups for statistical testing. Our results suggested that hTERT protein showed a significant negative correlation with the expression levels of miR-138-5p (r=−0.362, P=0.001) and miR422a (−0.306, P=0.005), while the correlation between hTERT and other miRNAs (miR-124-3p, miR-133a-3p, miR-133b, miR-150-5p and miR-378a-3p) revealed no significant negative correlation (Table IV). Therefore, the downregulated expression of miR-138-5p and miR-422a potentially inhibited hTERT expression.

Table IV

The relationship between the expression of miRNAs and hTERT protein expression in colorectal cancer tissues.

Table IV

The relationship between the expression of miRNAs and hTERT protein expression in colorectal cancer tissues.

GroupsTotal (84)hTERT
rP-value
− (24)+ (34)++ (16)+++ (10)
miR-124-3p−0.1470.183
 Low4282167
 High421613103
miR-133a-3p−0.2080.058
 Low4291788
 High42151782
miR-133b−0.0180.874
 Low42111966
 High421315104
miR-138-5p−0.3620.001a
 Low4361999
 High41181571
miR-150-5p−0.1850.092
 Low4281996
 High42161574
miR-378a-3p−0.0640.562
 Low4292175
 High42151395
miR-422a−0.3060.005a
 Low42717117
 High42171753

{ label (or @symbol) needed for fn[@id='tfn4-or-33-06-2728'] } Statistical analysis was performed by the Spearman’s rank-order correlation coefficient.

a P<0.05 was considered to be statistically significant; hTERT, human telomerase reverse transcriptase.

Relationship between miR-138-5p and miR-422a expression and clinicopathological factors in CRC patients

For statistical testing, we primarily divided patients into the high- and low-expression groups according to the median value of each miRNA. The expression levels of miR-138-5p and miR-422a were compared between different cohorts depending on various clinicopathological characteristics (Table I). There were no significant variations in miR-138-5p between the subgroups regarding age, gender, tumor size, tumor site, differentiation, the depth of invasion, lymph-node metastasis and TNM stage. However, a statistically significant difference in miR-138-5p expression was observed with regard to distant metastasis (P<0.000). A significant difference in miR-422a expression was identified between the subgroups according to lymph-node metastasis (P=0.023). However, the data showed no significant association between miR-422a relative expression levels and other parameters.

Downregulated miR-422a associated with shorter overall survival (OS)

The survival analysis of the 84 studied patients was implemented using information available from the clinical follow-ups. The median follow-up was 58 months (range, 8–86 months). At the end of follow-up, 62 patients succumbed, 22 patients remained alive, and the follow-up rate was 100%. Results of the Kaplan-Meier method and log-rank test showed that the OS of CRC patients with a high-expression miR-138-5p was longer than that of patients with low-expression miR-138-5p (the estimated median OS time was 59 and 50 months, respectively), albeit the difference was not statistically significant (P=0.432, Fig. 4A). However, patients with low-expression miR-422a had significantly poorer OS (P=0.024, Fig. 4B). The estimated median OS time was 61 months in the miR-422a high-expression group but 53 months in the miR-422a low-expression group. Our result suggested that a lower expression of miR-422a was associated with reduced OS in CRC patients.

Discussion

CRC is the third most common cancer in humans and the mortality of CRC accounts for ~9% of all cancer deaths (20). Therefore, gaining a better understanding of the biological behavior of the tumor is critical to improve treatment strategies and patient outcomes. The dysregulation of miRNAs and hTERT have been suggested to play a crucial role in the regulation of tumorigenesis and metastases of various types of cancer. The finding that miRNAs influence cell proliferation, apoptosis, metabolism, and transformation in many subtypes of cancer at a post-transcriptional level, has led to great attention being focused on novel tumor-suppressor oncogene-targeting miRNAs.

In this study, we initially identified 8 miRNAs that were potentially involved in the regulation of hTERT by using a combination of retrieving and analysing microRNA microarray data and bioinformatics analysis. The expression levels of the 7 miRNAs (miR-124-3p, miR-133a-3p, miR-133b, miR-138-5p, miR-150-5p and miR-378a-3p, miR-422a) were found to be significantly decreased in 84 pairs of the CRC tissues when compared with their matched corresponding normal tissues using RT-qPCR. Our results suggest that hTERT protein showed a significant negative correlation with the expression levels of miR-138-5p (r=−0.362, P=0.001) and miR422a (−0.306, P=0.005). Thus, miR-138-5p and miR-422a may be more likely to inhibit hTERT expression potentially compared to the remaining 5 miRNAs.

To the best of our knowledge, this is the first study to screen and validate preliminarily miRNAs with regulation of hTERT in CRC. Other studies have identified 3 different miRNAs that influence hTERT expression. miR-138 was the first demonstrated hTERT-targeting miRNA. Mitomo et al (13) have shown that the overexpression of miR-138 induced a reduction in hTERT protein expression in human anaplastic thyroid carcinoma. Additionally, using luciferase reporter assay those authors confirmed target specificity between miR-138 and the hTERT 3′-untranslated region. Chen et al (12) determined that miR-1207-5p and miR-1266 interact with the 3′UTR of hTERT and suppress gastric cancer growth and invasion by targeting hTERT. However, in addition to the main mechanism described above, miRNAs can also regulate the expression of hTERT through influence of other transcription factors. Wang et al (21) found that miR-21 regulates hTERT expression mediated by STAT3, thereby controlling glioblastoma cell growth. Moreover, the scope of functional miRNA-mRNA interactions have been expanded from RNA 3′UTRs to include the coding regions of the targeted RNAs (22). These mechanisms described above offered possible interpretations of the observed negative statistical association between the downregulated miR-138-5p and miR-422 and the overexpression of hTERT protein.

In contrast to hTERT promoting tumor metastasis, miR-138 and miR-422a have been found to be potential tumor suppressors in certain types of cancer. It has been shown that miR-138 may have an effect on tumor metastasis by targeting SOX4 and HIF1a in ovarian cancer and targeting MMP2/MMP9 in cholangiocarcinoma (23,24). Downregulation of miR-138 promotes metastasis by directly targeting TWIST2 and is associated with lymph-node metastasis, distant metastasis, and predicted poor prognosis in CRC (25). Previous findings suggested that miR-422a may play a protective role against CRC, which was shown by its decreased expression in CRC when compared to normal tissue (26). Furthermore, miR-422a can suppress tumor cell proliferation by inhibiting related pathways in osteosarcoma (27). Notably, miR-138-5p or miR-422a may have a negative connection with hTERT in tumor cell proliferation and metastasis. Thus, combined with the results of our study, the probability of miR-138-5p and miR-422a potentially inhibiting hTERT expression in CRC is valuable. However, this results remains to be confirmed in future studies

Similar to previous studies showing the downregulation of miR-138-5p and miR422a in cancer tissues, in our study, we investigated whether or not the decreased levels of miR-138-5p and miR-422a in CRC were associated with the clinicopathology and survival of patients. A statistically significant difference in miR-138-5p expression was observed with regard to distant metastasis (P<0.000) while a significant difference in miR-422a expression was also noted between subgroups according to lymph-node metastasis (P=0.023). In addition, we found that the high- vs. low-expression group of miR-422a showed a highly significant difference in CRC patients (P=0.024), which suggests that the downregulation of miR-422a was associated with a poorer prognosis.

The present study had some limitations. First, immunohistochemistry was used to detect hTERT protein expression in CRC instead of western blotting. Second, in the present analysis, elevated levels of miR-422a expression were found to have a prognostic role in CRC, but it was not possible to confirm miR-422a as an independent predictive factor. Third, validation of miRNAs with the regulation of hTERT in CRC requires a cell function test, which is to be conducted in future studies.

In conclusion, our results confirm that miR-124-3p, miR-133a-3p, miR-133b, miR-138-5p, miR-150-5p, miR-378a-3p and miR-422a expression levels were downregulated in CRC and that miR-138-5p and miR-422a were found to potentially interact with hTERT. Investigation of the suppression of malignant behavior of these miRNAs in CRC may be useful as a diagnostic or prognostic tool at least, and may contribute to the development of a new effective treatment for CRC.

Acknowledgments

This study was funded by the scientific research fund of Guangxi Zhuang Autonomous Region Education Department (no. 302304).

References

1 

Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al: The RNA component of human telomerase. Science. 269:1236–1241. 1995. View Article : Google Scholar : PubMed/NCBI

2 

Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Cukusić A, Skrobot Vidacek N, Sopta M and Rubelj I: Telomerase regulation at the crossroads of cell fate. Cytogenet Genome Res. 122:263–272. 2008. View Article : Google Scholar

4 

Poole JC, Andrews LG and Tollefsbol TO: Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene. 269:1–12. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Zhang Y, Chen X, Xu X, Wang X, Wang X, Yuan G, Sun D, Ka W, He D, Wen Z, et al: Knockdown of hTERT alters biophysical properties of K562 cells resulting in decreased migration rate in vitro. Cell Biochem Biophys. 61:595–603. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Bertorelle R, Briarava M, Rampazzo E, Biasini L, Agostini M, Maretto I, Lonardi S, Friso ML, Mescoli C, Zagonel V, et al: Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer. Br J Cancer. 108:278–284. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Daniel M, Peek GW and Tollefsbol TO: Regulation of the human catalytic subunit of telomerase (hTERT). Gene. 498:135–146. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Schetter AJ, Okayama H and Harris CC: The role of microRNAs in colorectal cancer. Cancer J. 18:244–252. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Chen L, Lü MH, Zhang D, Hao NB, Fan YH, Wu YY, Wang SM, Xie R, Fang DC, Zhang H, et al: miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis. 5:e10342014. View Article : Google Scholar : PubMed/NCBI

13 

Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, et al: Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci. 99:280–286. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A and Smyth GK: A comparison of background correction methods for two-colour microarrays. Bioinformatics. 23:2700–2707. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Kayala MA and Baldi P: Cyber-T web server: differential analysis of high-throughput data. Nucleic Acids Res. 40(W1): W553–W559. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Baldi P and Long AD: A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics. 17:509–519. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Dweep H, Gretz N and Sticht C: miRWalk database for miRNA-target interactions. Methods Mol Biol. 1182:289–305. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

19 

Li J, Cao X, Fang Y, Liao ZE, Liu YY, Huang BD and Han YJ: Overexpression of hTERT in potentially malignant colorectal laterally spreading tumors. Mol Med Rep. 7:1409–1412. 2013.PubMed/NCBI

20 

Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Wang YY, Sun G, Luo H, Wang XF, Lan FM, Yue X, Fu LS, Pu PY, Kang CS, Liu N, et al: miR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth. CNS Neurosci Ther. 18:722–728. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Chi SW, Zang JB, Mele A and Darnell RB: Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature. 460:479–486. 2009.PubMed/NCBI

23 

Yeh YM, Chuang CM, Chao KC and Wang LH: MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Wang Q, Tang H, Yin S and Dong C: Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep. 29:2046–2052. 2013.PubMed/NCBI

25 

Long L, Huang G, Zhu H, Guo Y, Liu Y and Huo J: Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med. 11:2752013. View Article : Google Scholar : PubMed/NCBI

26 

Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K, Kiss I, et al: Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med. 16:2655–2666. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A, Blay JY and Alberti L: Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer. 129:680–690. 2011. View Article : Google Scholar

Related Articles

Journal Cover

June-2015
Volume 33 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qin Y, Xie X, Liu H, Lai H, Qiu H and Ge L: Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer. Oncol Rep 33: 2728-2736, 2015
APA
Qin, Y., Xie, X., Liu, H., Lai, H., Qiu, H., & Ge, L. (2015). Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer. Oncology Reports, 33, 2728-2736. https://doi.org/10.3892/or.2015.3892
MLA
Qin, Y., Xie, X., Liu, H., Lai, H., Qiu, H., Ge, L."Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer". Oncology Reports 33.6 (2015): 2728-2736.
Chicago
Qin, Y., Xie, X., Liu, H., Lai, H., Qiu, H., Ge, L."Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer". Oncology Reports 33, no. 6 (2015): 2728-2736. https://doi.org/10.3892/or.2015.3892